Elanco Animal Health Inc
ELAN NYSE
SEC CIK 1739104
Follow Elanco Animal Health
Weekly email: filings, results
Revenue, last quarter
$1.3B
+11.3% vs same quarter last year
Net income
$18M
+152.9% vs same quarter last year
EPS, diluted
$0.04
+157.1% vs same quarter last year
Operating cash flow
$216M
−1.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $4.7B | −$232M |
| FY24 | $4.4B | $338M |
| FY23 | $4.4B | −$1.2B |
| FY22 | $4.4B | −$78M |
| FY21 | $4.8B | −$483M |
| FY20 | $3.3B | −$574M |
| FY19 | $3.1B | $68M |
| FY18 | $3.1B | $86.5M |
| FY17 | $2.9B | −$310.7M |
| FY16 | $2.9B | −$47.9M |
| FY15 | - | - |
- Gross margin
- Net margin
Show the numbers
| Year | Gross margin | Net margin |
|---|---|---|
| FY25 | 55% | −4.9% |
| FY24 | 54.9% | 7.6% |
| FY23 | 56.3% | −27.9% |
| FY22 | 56.6% | −1.8% |
| FY21 | 55.2% | −10.1% |
| FY20 | 49.1% | −17.5% |
| FY19 | 52.1% | 2.2% |
| FY18 | 48.7% | 2.8% |
| FY17 | 48.3% | −10.8% |
| FY16 | 51.6% | −1.6% |
| FY15 | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | $284M |
| FY24 | $394M |
| FY23 | $131M |
| FY22 | $281M |
| FY21 | $324M |
| FY20 | −$176M |
| FY19 | $84M |
| FY18 | $352.8M |
| FY17 | $75.2M |
| FY16 | $45.6M |
| FY15 | - |
- Elanco Animal Health
- Healthcare median
Show the numbers
| Year | Elanco Animal Health | Healthcare median |
|---|---|---|
| FY25 | −4.9% | −30.6% |
| FY24 | 7.6% | −47% |
| FY23 | −27.9% | −58% |
| FY22 | −1.8% | −80.4% |
| FY21 | −10.1% | −71.9% |
| FY20 | −17.5% | −62.2% |
| FY19 | 2.2% | −46.3% |
| FY18 | 2.8% | −49.6% |
| FY17 | −10.8% | −45.9% |
| FY16 | −1.6% | −36% |
| FY15 | - | −38.4% |